Kerri-Ann Millar
VP-Finance, Cue Biopharma, Inc.
Companies
- Cue Biopharma, Inc.Chief financial officer Aug 25, 2020 to Aug 3, 20261
- Cue Biopharma, Inc.VP-Finance May 11, 2018 to Feb 12, 20202
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Cue Biopharma, Inc. CUE14,311 shares3$240.6K at $16.81Aug 22, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 22, 2022Shares withheld for tax 2,828 shares at $3.05 of Cue Biopharma, Inc.3
- Aug 21, 2022Exercised options 6,667 shares of Cue Biopharma, Inc.3
- Oct 1, 2021Sold 1,251 shares at $14.21 of Cue Biopharma, Inc.4
- Oct 1, 2021Exercised options 1,251 shares at $7.50 of Cue Biopharma, Inc.4
- Aug 23, 2021Shares withheld for tax 1,961 shares of Cue Biopharma, Inc.4
- Aug 23, 2021Exercised options 6,667 shares of Cue Biopharma, Inc.4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARCue Biopharma, Inc., VP-Finance
- 3
- 4SEC EDGARForm 4 filed Oct 5, 2021